Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP909355.RAiSKf_gUJHsfNtuIZmrqkyXg_YcHmYowijJFVoKmN6Ao130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP909355.RAiSKf_gUJHsfNtuIZmrqkyXg_YcHmYowijJFVoKmN6Ao130_provenance.
• NP356138.RAxatprDDOby7PU17dHKp-e041l4nkx8PZ-DVPUBeJPZA130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP356138.RAxatprDDOby7PU17dHKp-e041l4nkx8PZ-DVPUBeJPZA130_provenance.
• NP229617.RAbmTJ3LVw3iPE6SXBU7oVDP5yc-A18HdZawmyYAJQtns130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP229617.RAbmTJ3LVw3iPE6SXBU7oVDP5yc-A18HdZawmyYAJQtns130_provenance.
• NP254828.RApA1G4xS-RjFEkzSze7sfm3ztossZDRlbQUIfZbl7nGs130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254828.RApA1G4xS-RjFEkzSze7sfm3ztossZDRlbQUIfZbl7nGs130_provenance.
• NP286871.RAhjXeGToK_CBg-GpZD6rs01dbnKXimcVFiScD-M8gcIQ130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286871.RAhjXeGToK_CBg-GpZD6rs01dbnKXimcVFiScD-M8gcIQ130_provenance.
• NP729754.RABQiwkkgGRj0KTc4acA_yBAW3aSPe2K8GnSFPbfPwuDg130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP729754.RABQiwkkgGRj0KTc4acA_yBAW3aSPe2K8GnSFPbfPwuDg130_provenance.
• NP431304.RAvSG3JGIVq4mipMYCA7dK5bOp5SbYxS2jhbrbfnKONKc130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431304.RAvSG3JGIVq4mipMYCA7dK5bOp5SbYxS2jhbrbfnKONKc130_provenance.
• assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP274346.RAUanjAq-JW5Llx5plYzaUI7znGX8E6DVb-OgNgpq1S_k130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP274346.RAUanjAq-JW5Llx5plYzaUI7znGX8E6DVb-OgNgpq1S_k130_provenance.
• NP593994.RAEGr1jyN61wqOUgVm3rHYWtzt5v0wYfIKsK9Bfa8dlj4130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593994.RAEGr1jyN61wqOUgVm3rHYWtzt5v0wYfIKsK9Bfa8dlj4130_provenance.
• NP426215.RAZgDLjoPdYUTqu4QGdxDFlGRj9wJwEmtegJsgI9GsUyI130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP426215.RAZgDLjoPdYUTqu4QGdxDFlGRj9wJwEmtegJsgI9GsUyI130_provenance.
• NP426217.RARzPkKKJGoDV0s_DSj0Idd8bY0VWG09dDwfgVTu6waII130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP426217.RARzPkKKJGoDV0s_DSj0Idd8bY0VWG09dDwfgVTu6waII130_provenance.
• NP274344.RApjEtZ7IM7Qwxw_owj9sSf3cFau0jkAHMA6gLDsVCCpc130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP274344.RApjEtZ7IM7Qwxw_owj9sSf3cFau0jkAHMA6gLDsVCCpc130_provenance.
• NP274357.RAj5ikH42JgdKeSyszuXkmu2nc4_wm05j_q6jt9Jaq9VY130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP274357.RAj5ikH42JgdKeSyszuXkmu2nc4_wm05j_q6jt9Jaq9VY130_provenance.
• NP274362.RAgN5Cz1voFJif3Uoo5QzbPXDDdJbC_16E0R-Js34Aczg130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP274362.RAgN5Cz1voFJif3Uoo5QzbPXDDdJbC_16E0R-Js34Aczg130_provenance.
• NP294945.RAltY55zrW5xMBZ9ASBgDxOXayX_822qbTLawATjZUzuU130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294945.RAltY55zrW5xMBZ9ASBgDxOXayX_822qbTLawATjZUzuU130_provenance.
• NP426213.RAhI0yLfJpuhiNeW68mAZBrkbrAdHmiI6mfdNDya51N94130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP426213.RAhI0yLfJpuhiNeW68mAZBrkbrAdHmiI6mfdNDya51N94130_provenance.
• NP294673.RAyVBkDVVrTuPq2nfSk8cEjwrvSiTP26LtmLeQiVSNGgY130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294673.RAyVBkDVVrTuPq2nfSk8cEjwrvSiTP26LtmLeQiVSNGgY130_provenance.
• NP294656.RAKfJo0SXechy2d6imr7OnGrM2LbAqRG3GskrJyXwFZfg130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294656.RAKfJo0SXechy2d6imr7OnGrM2LbAqRG3GskrJyXwFZfg130_provenance.
• NP294887.RAKCQVHxSPCUv2Cc-i8pVhDJXfwTYiYCh__bPtV_Qs4K8130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294887.RAKCQVHxSPCUv2Cc-i8pVhDJXfwTYiYCh__bPtV_Qs4K8130_provenance.
• NP426212.RA1TJpx-x14nDn77mtQid9jopME_KUfNsqNO_jUfwCkDY130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP426212.RA1TJpx-x14nDn77mtQid9jopME_KUfNsqNO_jUfwCkDY130_provenance.
• NP426214.RA3mPq3piYc_ff874GrJGZ9GdRHzJwP1HyGcjCsQq-8Y4130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP426214.RA3mPq3piYc_ff874GrJGZ9GdRHzJwP1HyGcjCsQq-8Y4130_provenance.
• NP426216.RAw-HJSLVajkP-hcRF3hinTrhQT6zGWgBye5FFiWYjaXw130_assertion description "[In situ hybridization of metastatic and nonmetastatic ovarian cancer demonstrated selective expression of bone marrow stromal antigen 2 and tumor necrosis factor receptor superfamily member 5 in the metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP426216.RAw-HJSLVajkP-hcRF3hinTrhQT6zGWgBye5FFiWYjaXw130_provenance.